Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Brand

Showing results (51-60 of 124) with videos related to

Pageof 13
Sort By:
Orphanet Journal of Rare Diseases|December 28, 2024
Impact of enzyme replacement therapy on clinical manifestations in females with Fabry diseaseMalte Lenders, Albina Nowak, Markus Cybulla, et al.
Clinical Epigenetics|October 20, 2017
Promoter methylation inhibits expression of tumor suppressor KIBRA in human clear cell renal cell carcinomaKatrin Schelleckes, Boris Schmitz, Giuliano Ciarimboli, et al.
Journal of Molecular Medicine (Berlin, Germany)|September 28, 2013
Tissue-specific differences in the regulation of KIBRA gene expression involve transcription factor TCF7L2 and a complex alternative promoter systemKatrin Guske, Boris Schmitz, Michael Schelleckes, et al.
Molecular Genetics and Metabolism|May 19, 2023
An expert consensus on the recommendations for the use of biomarkers in Fabry diseaseAlessandro Burlina, Eva Brand, Derralynn Hughes, et al.
Hypertension (Dallas, Tex. : 1979)|August 20, 2008
Characterization and functional analyses of the human G protein-coupled receptor kinase 4 gene promoterSandra Hasenkamp, Ralph Telgmann, Jan A Staessen, et al.
Journal of Hypertension|June 18, 2004
Angiotensinogen promoter haplotypes are associated with blood pressure in untreated hypertensivesStefan-Martin Brand-Herrmann, Karla Köpke, Florian Reichenberger, et al.
Molecular Genetics and Metabolism|September 13, 2023
Screening for health-related quality of life and its determinants in Fabry disease: A cross-sectional multicenter studyYaroslav Winter, Max Hilz, Felix Beuschlein, et al.
Frontiers in Immunology|December 31, 2020
Case Report: A Spinal Ischemic Lesion in a 24-Year-Old Patient With Fabry DiseaseJulia Krämer, Felix Glaser, Martin Hasselblatt, et al.
Frontiers in Physiology|June 15, 2017
Dose-Response of High-Intensity Training (HIT) on Atheroprotective miRNA-126 LevelsBoris Schmitz, Katrin Schelleckes, Johanna Nedele, et al.
Hypertension (Dallas, Tex. : 1979)|December 15, 2010
C-reactive protein makes human endothelium stiff and tightKristina Kusche-Vihrog, Katarina Urbanova, Anja Blanqué, et al.
Pageof 13

Showing results (51-60 of 124) with videos related to

Sort By:
Pageof 13
Orphanet Journal of Rare Diseases|December 28, 2024
Impact of enzyme replacement therapy on clinical manifestations in females with Fabry diseaseMalte Lenders, Albina Nowak, Markus Cybulla, et al.
Clinical Epigenetics|October 20, 2017
Promoter methylation inhibits expression of tumor suppressor KIBRA in human clear cell renal cell carcinomaKatrin Schelleckes, Boris Schmitz, Giuliano Ciarimboli, et al.
Journal of Molecular Medicine (Berlin, Germany)|September 28, 2013
Tissue-specific differences in the regulation of KIBRA gene expression involve transcription factor TCF7L2 and a complex alternative promoter systemKatrin Guske, Boris Schmitz, Michael Schelleckes, et al.
Molecular Genetics and Metabolism|May 19, 2023
An expert consensus on the recommendations for the use of biomarkers in Fabry diseaseAlessandro Burlina, Eva Brand, Derralynn Hughes, et al.
Hypertension (Dallas, Tex. : 1979)|August 20, 2008
Characterization and functional analyses of the human G protein-coupled receptor kinase 4 gene promoterSandra Hasenkamp, Ralph Telgmann, Jan A Staessen, et al.
Journal of Hypertension|June 18, 2004
Angiotensinogen promoter haplotypes are associated with blood pressure in untreated hypertensivesStefan-Martin Brand-Herrmann, Karla Köpke, Florian Reichenberger, et al.
Molecular Genetics and Metabolism|September 13, 2023
Screening for health-related quality of life and its determinants in Fabry disease: A cross-sectional multicenter studyYaroslav Winter, Max Hilz, Felix Beuschlein, et al.
Frontiers in Immunology|December 31, 2020
Case Report: A Spinal Ischemic Lesion in a 24-Year-Old Patient With Fabry DiseaseJulia Krämer, Felix Glaser, Martin Hasselblatt, et al.
Frontiers in Physiology|June 15, 2017
Dose-Response of High-Intensity Training (HIT) on Atheroprotective miRNA-126 LevelsBoris Schmitz, Katrin Schelleckes, Johanna Nedele, et al.
Hypertension (Dallas, Tex. : 1979)|December 15, 2010
C-reactive protein makes human endothelium stiff and tightKristina Kusche-Vihrog, Katarina Urbanova, Anja Blanqué, et al.
Pageof 13